Patents by Inventor Allen H. Heller

Allen H. Heller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FOSPROPOFOL METHODS AND COMPOSITIONS
    Publication number: 20230277567
    Abstract: The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof. Pharmaceutical compositions comprising fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, and methods of treating diseases or disorders, including migraine are also disclosed.
    Type: Application
    Filed: February 15, 2023
    Publication date: September 7, 2023
    Inventors: Steven L. Krill, Feng-Jing Chen, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller
  • Fospropofol methods and compositions
    Patent number: 11628178
    Abstract: The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof. Pharmaceutical compositions comprising fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, and methods of treating diseases or disorders, including migraine are also disclosed.
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: April 18, 2023
    Assignee: Epalex Corporation
    Inventors: Steven L. Krill, Feng-Jing Chen, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller
  • PROPOFOL PRODRUG METHODS AND COMPOSITIONS
    Publication number: 20230084521
    Abstract: The present disclosure pertains to the use of propofol prodrugs, pharmaceutically acceptable salts of propofol prodrugs, or mixtures thereof, to treat migraine.
    Type: Application
    Filed: September 9, 2022
    Publication date: March 16, 2023
    Inventors: Michael A. Rogawski, Enrique Carrazana, Edward Brendan Magrab, Steven L. Krill, Allen H. Heller
  • FOSPROPOFOL METHODS AND COMPOSITIONS
    Publication number: 20220105111
    Abstract: The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, to treat migraine.
    Type: Application
    Filed: March 26, 2020
    Publication date: April 7, 2022
    Inventors: Michael A. Rogawski, Enrique Carrazana, Edward Brendan Magrab, Steven L. Krill, Allen H. Heller
  • MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT
    Publication number: 20210145731
    Abstract: A method of administering diazepam with a multimodal delivery profile is described.
    Type: Application
    Filed: November 14, 2020
    Publication date: May 20, 2021
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie M. Varjan, Stephen Paul WARGACKI, Gary SLATKO, Allen H. Heller